Cargando…

Predictive value of LN metastasis detected by (18)F-FDG PET/CT in patients with papillary thyroid cancer receiving iodine-131 radiotherapy

The aim of the present study was to predict the prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in the metastatic lymph nodes (mLNs) of patients with papillary thyroid carcinoma (PTC) with a negative iodine-131 ((131)I) whole-body scan (WB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chao, Zhang, Jian, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607093/ https://www.ncbi.nlm.nih.gov/pubmed/31423231 http://dx.doi.org/10.3892/ol.2019.10500

Ejemplares similares

Skeletal Muscle Metastasis in Papillary Thyroid Microcarcinoma Evaluated by F18-FDG PET/CT
por: Hitu, Liviu, et al.
Publicado: (2020)

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
por: Salvatore, Barbara, et al.
Publicado: (2017)

The role of 18F-FDG PET/CT testing in the management of a papillary thyroid carcinoma
por: Florczak, Agnieszka, et al.
Publicado: (2013)

Hiatal hernia uptake of iodine-131 mimicking mediastinal metastasis of papillary thyroid carcinoma
por: Haghighatafshar, Mahdi, et al.
Publicado: (2015)

AN UNUSUAL CASE OF PAPILLARY THYROID CARCINOMA IODINE-131 AVID METASTASIS TO THE ADRENAL GLAND
por: Blažeković, Ivan, et al.
Publicado: (2018)

Clinical role of (18)F-FDG PET/CT for detection of radioactive iodine refractory differentiated thyroid cancer
por: Tang, Xiaowei, et al.
Publicado: (2023)

Findings of I-131 SPECT/CT, (18)F-FDG, and (68)Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma
por: Tatar, Gamze, et al.
Publicado: (2023)

Incremental diagnostic value of [(18)F]tetrafluoroborate PET-CT compared to [(131)I]iodine scintigraphy in recurrent differentiated thyroid cancer
por: Dittmann, Matthias, et al.
Publicado: (2020)

Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers
por: Roy, Malanie, et al.
Publicado: (2022)

Diagnostic Performance of (18)F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative (131)I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level
por: Qiu, Zhong-Ling, et al.
Publicado: (2017)

The (18)F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes
por: Choi, Jinhyun, et al.
Publicado: (2018)

(18)F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study
por: Farina, Eleonora, et al.
Publicado: (2017)

Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer
por: Yoon, Seokho, et al.
Publicado: (2015)

Adrenocortical Oncocytic Carcinoma and Papillary Thyroid Carcinoma Incidentally Detected in an Asymptomatic Patient by F-18 FDG PET/CT
por: Al Balooshi, Batool, et al.
Publicado: (2018)

Prognostic Role of 2-[(18)F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative (131)I WBS and Positive 2-[(18)F]-FDG PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on (18)F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma
por: Jung, Ji-hoon, et al.
Publicado: (2015)

Efficacy of (18)F-fluorodeoxyglucose PET/CT for Detecting Lymph Node Metastasis in Papillary Thyroid Carcinoma
por: Lee, Dong Won, et al.
Publicado: (2018)

(18)F-FDG PET/CT-Guided Clinical Management of the Rare Aggressive "Columnar-Cell" Variant of Papillary Thyroid Cancer
por: Vadrucci, Manuela, et al.
Publicado: (2016)

F-18 FDG-PET-CT in the Diagnostic of a Late Medullary Thyroid Carcinoma Recurrence in a Patient with Follicular-Papillary Thyroid Cancer
por: Piciu, Doina, et al.
Publicado: (2014)

Thyroid Incidentalomas on (18)F-FDG PET/CT: Clinical Significance and Controversies
por: Makis, William, et al.
Publicado: (2017)

The Role of (18)F-FDG PET/CT in the Management of the Autoimmune Thyroid Diseases
por: Małkowski, Bogdan, et al.
Publicado: (2019)

Evaluation of Malignancy Risk in 18F-FDG PET/CT Thyroid Incidentalomas
por: Larg, Maria-Iulia, et al.
Publicado: (2019)

Predicting (131)I-avidity of metastases from differentiated thyroid cancer using (18)F-FDG PET/CT in postoperative patients with elevated thyroglobulin
por: Liu, Min, et al.
Publicado: (2018)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

(18)F-FDG PET/CT Findings of Leptomeningeal Metastasis in Nasopharyngeal Carcinoma
por: Montanarella, Matthew, et al.
Publicado: (2023)

Cardiac Metastasis of Malignant Melanoma Detected by (18)F-FDG PET/CT
por: Zhang, Hongzhe, et al.
Publicado: (2023)

(18)FDG PET/CT in Pulmonary Carcinosarcoma and Brain Metastasis
por: Abbasain, Hamideh, et al.
Publicado: (2019)

Renal Metastasis and Dual ((18)F-Fluorodeoxyglucose and (131)I) Avid Skeletal Metastasis in a Patient with Papillary Thyroid Cancer
por: Kulkarni, Prashanth, et al.
Publicado: (2017)

Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer
por: Byun, Byung Hyun, et al.
Publicado: (2013)

Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC)
por: Lodi Rizzini, Elisa, et al.
Publicado: (2021)

Impact of (18)F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative (131)I whole body scan and elevated serum thyroglobulin
por: Boktor, Raef R., et al.
Publicado: (2022)

Pituitary (18)F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on (18)F-FDG PET/CT
por: Ding, Yingli, et al.
Publicado: (2019)

[(18)F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results
por: Sollini, M., et al.
Publicado: (2017)

The Use of (18)F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer
por: Ekmekçioğlu, Özgül
Publicado: (2021)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis
por: Yao, Lan, et al.
Publicado: (2021)

Analysis of predictability of F‐18 fluorodeoxyglucose‐PET/CT in the recurrence of papillary thyroid carcinoma
por: Kim, Suk Kyeong, et al.
Publicado: (2016)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4tje6jvnn7vukdcp9ehnni0j66